MedTrace Logo

Internet-based Program for Prevention and Early Intervention of Adolescent Depression

NCT03521388 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 947

Last updated 2019-09-27

No results posted yet for this study

Summary

Background: Depression is prevalent and can have devastating effects on the life of adolescents. Computerized intervention programs for depression have shown positive results. There is less evidence in prevention and early treatment for depression in Latin American adolescents.

Purpose: The purpose of this study is to determine whether a stepped internet-based program is effective to prevent and early intervene depression in adolescents attending 9th to 11th grade in eight schools in Santiago, Chile.

Study design: A two-arm cluster-randomized clinical trial will be carried out with approximately 600 adolescents.

Conditions

  • Depressive Symptoms

Interventions

BEHAVIORAL

Take care of your mood (CUIDA TU ANIMO in Spanish)

The adolescents will be registered in the Website www.cuidatuanimo.org

OTHER

Control

The adolescents will visit the Website www.cuidatuanimo.org, but they can not register

Sponsors & Collaborators

  • Comisión Nacional de Investigación Científica y Tecnológica

    collaborator OTHER_GOV

  • Millennium Institute for Research in Depression and Personality (MIDAP)

    collaborator UNKNOWN

  • University of Chile

    lead OTHER

Principal Investigators

  • Vania Martinez, PhD · University of Chile

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
13 Years
Max Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-18
Primary Completion
2019-05-31
Completion
2019-08-31

Countries

  • Chile

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03521388 on ClinicalTrials.gov